This special edition on antimicrobial stewardship in solid organ transplant recipients is a culmination of efforts over several years, including the publication of the white paper in the American Journal of Transplantation. 1 Despite almost 30 years of antimicrobial stewardship initiatives, the ability to develop programs, obtain data, and improve outcomes in transplant patients are scarce. Also, most of the initiatives published and regulatory mandates are within North America. However, traditional stewardship models on antibiotic restrictions and cost savings are difficult to sell to transplant programs and implement with this complicated patient population and may not be applicable in the global setting. Often the greatest barrier is having an